Article info
PDFEditorial commentary
Implications of confirmed de novo pathogenic SOD1 mutations
- Correspondence to Dr Johnathan Cooper-Knock, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK; j.cooper-knock{at}sheffield.ac.uk
Citation
Implications of confirmed de novo pathogenic SOD1 mutations
Publication history
- Received September 19, 2021
- Accepted September 22, 2021
- First published October 1, 2021.
Online issue publication
July 06, 2022
Article Versions
- Previous version (6 July 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.